Nrf2 is strongly upregulated in active MS lesions, with the expression of Nrf2-responsive genes being predominantly found in areas of initial myelin destruction (Licht-Mayer et al., 2015). This evidence concerns the gene NFE2L2 and myeloid sarcoma.